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Table 3. Pulsed wave tissue Doppler recordings
Normal group n¼15 Mild-moderate MS n¼20 Severe MS n¼15
Long axis
SW1 (cm/s) 10.7 +/- 2.3* 7.9 +/- 1.3 6.2 +/- 1.4
SW2 (cm/s) 5.4 +/- 0.7 6.0 +/- 1.2** 4.7 +/- 1.2
Q-SW1 (ms) 145 +/- 32A 199 +/- 43 180 +/- 46
Q-SW2 (ms) 259 +/- 37 258 +/- 43 258 +/- 44
Short axis
SW1 (cm/s) 7.5 +/- 1.2 7.1 +/- 1.2 7.0 +/- 1.4
SW2 (cm/s) 4.8 +/- 1.0 5.5 +/- 1.1 5.5 +/- 1.3
Q-SW1 (ms) 182 +/- 28 178 +/- 38 168 +/- 28
Q-SW2 (ms) 298 +/- 41* 245 +/- 37 234 +/- 26
*p < 0.001 compared to mild-moderate and severe MS; **p < 0.01 compared to severe MS;
Ap¼0.001 compared to mild-moderate MS MS: mitral stenosis; SW1: ﬁrst systolic velocity
peak, SW2: second systolic velocity peak; Q-SW1: the duration from Q wave to SW1; Q-SW2:
the duration from Q wave to SW2
Table 4. The correlation between mitral valve area and pulsed wave tissue
Doppler parameters
Mitral valve area
SW1 long axis
Pearson correlation
Sig. (2-tailed)
-,431**
,002
SW2 long axis
Pearson correlation
Sig. (2-tailed)
,226
,115
Q-SW1 long axis
Pearson correlation
Sig. (2-tailed)1
0,483**
,000
Q-SW2 long axis
Pearson correlation
Sig. (2-tailed)
-,008
,955
SW 1 short axis
Pearson correlation
Sig. (2-tailed)2
-,116
,423
SW2 short axis
Pearson correlation
Sig. (2-tailed)
,228
,111
Q-SW1 short axis
Pearson correlation
Sig. (2-tailed)
-,036
,803
Q-SW2 short axis
Pearson correlation
Sig. (2-tailed)
-,471**
,001
SW1: ﬁrst systolic velocity peak, SW2: second systolic velocity peak; Q-SW1: the duration from
Q wave to SW1; Q-SW2: the duration from Q wave to SW2
Table 2. Echocardiographic ﬁndings
Normal group
n¼15
Mild-moderate
MS n¼20
Severe MS
n¼15
Mitral valve area(mm2) > 40 14 +/- 1.7 10 +/- 0.8
Mean mitral gradient (mmhg) ——— 6.8 +/- 3 10.8 +/- 2.1
IVS (mm) 8.4 +/- 0.7** 9.6 +/- 0.9 9.4 +/- 1.1
LVPW (mm) 8.6 +/- 0.6 9.6 +/- 0.94 9.0 +/- 1.2
LAD(mm) 33 +/- 2* 44 +/- 3 46 +/- 5
LVDD(mm) 28 +/- 3 29 +/- 4 28 +/- 3
LVSD(mm) 44 +/-2 46 +/- 3 43 +/- 10
FS(%) 35 +/- 3 35 +/- 4 36 +/- 4
EF(%) 65 +/- 3 65 +/- 6 65 +/- 5
SPAP(mmhg) 23 +/- 2( ) 36 +/-12A 52 +/- 13
*p<0.001compared to mild-moderate and severe MS;**p< 0.05 compared to mild-
moderate and severe (p< 0.01 compared to mild-moderate MS; ) p< 0.001 compared to
severe MS; A p< 0.001 compared to severe MS; MS: mitral stenosis; IVS:interventricular
septum; LVPW: left ventricular posterior wall; LAD: left atrial diameter, LVDD: left ventricular
diastolic diameter; LVSD: left venticular systolic diameter; FS: fractional shortening; EF:
ejection fraction; SPAP: systolic pulmonary artery pressure.
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Objectıves: Benign prostatic hyperplasia (BPH) and lower urinary tract symptoms
(LUTS) are most common disorders in elderly men. Although focused on hormones
and genetic predisposition, the pathophysiology of BPH remains unclear, but it seems
to be multifactorial. Currently, we have a lot of data about the relationship between the
atherosclerosis and BPH, but association between subclinical atherosclerosis and this
disease have not been evaluated in detail yet. In the present study we aimed to assess
the relationship between subclinical atherosclerosis and BPH, using epicardial fat
thickness (EFT) and carotid intima-media thickness (CIMT).
Methods: One hundred six men (including 56 patients with BPH and LUTS and
control group which consisted of 50 healthy men with no clinical signs of BPH) were
evaluated prospectively. Bladder outlet obstruction as veriﬁed by urodynamic testing,
the prostate volume was calculated using abdominal ultrasonography and LUTS were
evaluated using the international prostate symptom score (IPSS) and according to
IPSS, patients were divided into two groups as mild - moderate (<20 point) and severe
(20 point). EFT measured by transthoracic echocardiography (ECHO) and CIMT
evaluated by ultrasonography (USG). The relationship between EFT, CIMT and
another parameters was analysed.
Results: EFT, CIMT and fasting blood glucose were signiﬁcantly higher in BPH
group (p <0.001; p <0.001 and p¼0.042, respectively) (Table 1). At multivariate
logistic regression analysis EFT and CIMT were found to be independent predictors
of BPH (Table 2). EFT and CIMT demonstrated an increase from IPSS <20 point
to IPSS 20 point (p<0.001 and p¼0.003, respectively). In order to prediction of
severe LUTS (IPSS 20 point); receiver operating characteristic curve (ROC)
analysis revealed a cut off value of 3.5mm for EFT (AUC ¼ 0.88, 95% CI %81.8-
%99.3, p<0.001) with a speciﬁcity of %91,9 and a sensitivity of %84.2 and 0.9mm
for CIMT (AUC ¼ 0.75, 95% CI %47.5- %79.8, p<0.001) with a speciﬁcity of %
64.9 and a sensitivity of %84.2 (Figure 1). At the bivariate correlation analysis;
EFT and CIMT were negative correlation between Q max (r¼-0.468, p<0.001,
r¼-0.525, p<0.001 respectively) (Table 3).
Conclusıon: The present results support the hypothesis that subclinical atherosclerosis
might have a role in the development of BPH and it can be predicted non-invasively
with EFT and CIMT.Table 2
Multivariate OR(95% CI) Multivariate p value
EFT 2.65 (1.37-5.12) P ¼ 0.004
CIMT 15.62 (1.28-200.00) P ¼ 0.031
FBG 0.96 (0.92-1.00) P ¼ 0.061
The predictors of BPH in logistic regression analysis
Table 3
Prostate volume, mL PVR, mL Qmax, mL/s
EFT r ¼ 0.162, p ¼ 0.232 r ¼ 0.257, p ¼ 0.056 r ¼ -0.468, p < 0.001
CIMT r ¼ 0.172, p ¼ 0.206 r ¼ 0.238, p ¼ 0.078 r ¼ -0.525, p < 0.001
Results of correlation analysis
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Table 1
BPH Group (n ¼ 56) Control Group (n¼50) p value
Age, years 59.0  5.9 56.9  7.2 0.103
BMI, kg/m2 28.4  4.4 30.9  21.5 0.416
WM, cm 96.6  9.7 95.6  11.1 0.603
HM, cm 100.4  7.3 98.6  8.9 0.262
HT duration, years 2.9 4.9 2.1  3.2 0.300
Smoking duration,
years
8.5 15.2 11.0 15.1 0.402
EFT, mm 3.5  1.3 2.5  0,7 <0.001
CIMT, mm 1.0  0.3 0.8 0.2 <0.001
IVS, mm 11.5  3.0 12.0  1.9 0.321
LVEDD, mm 46.7  7.3 49.4  8.8 0.092
LVEDS, mm 32.5  7.8 31.9  7.1 0.642
PW, mm 11.9  6.7 12.0  1.6 0.937
EF, % 64.0  7.7 64.9  8.7 0.565
E, cm/sn 59.6  16.7 66.5  20.3 0.059
A, cm/sn 70.6  18.9 73.8  16.2 0.354
Em, cm/sn 10.3 5.3 9.8  3.5 0.559
Am, cm/sn 11.9  4.2 11.7  3.5 0.800
S, cm/sn 9.6  2.2 9.3  2.0 0.448
FBG, mg/dl 95.7  15.9 101.3  12.2 0.042
Creatinine, mg/dl 0.9  0.1 1.1  1.1 0.184
GFR, ml/min/1.73 m2 81.6  22.9 102.0  90.2 0.125
Total chelosterol, mg/dl 198.5  44.6 197.0  41.1 0.852
Triglycerides, mg/dl 137.2  73.7 155.1  70.6 0.203
HDL chelosterol, mg/dl 48.9 13.3 44.3  10.8 0.053
LDL chelosterol, mg/dl 121.2  40.9 130.9  37.0 0.203
Characteristics of patients BMI: body mass index; WM: waist measure; HM: Hip measure; HT:
hypertension; IVS: interventricular septum; LVEDD: left ventricle end diastolic diameter;
LVESD: left ventricle end sistolic diameter; PW: posterior wall; EF: ejection fraction; E: trans
mitral doppler E wave; A: trans mitral doppler A wave; Em: lateral mitral annular tissue
doppler E wave; Am: lateral mitral annular tissue doppler A wave; S: lateral mitral annular
tissue doppler S wave FBG: fasting blood glucose; GFR: glomerular ﬁltration rate; HDL: high
density lipoprotein; LDL:low density lipoprotein.
Table1
Before
PMBV
After
PMBV
3st
month
1 st
year p* P1** P2** P3** P4**
LAV max
(ml/m2)
59
(42-76)
48
(34-62)
44
(29-59)
43
(28-57)
<0,01 <0,01 <0,01 <0,01 <0,01
LAV min
(ml/m2)
33
(20-45)
27
(14-38)
24
(11-36)
23
(10-35)
<0,01 <0,01 <0,01 <0,01 <0,01
LATEF
(%)
0,43
(0,32-
0.69)
0.45
(0.35-
0.66)
0.45
(0.33-
0.65)
0.45
(0.31-
0.66)
0,05 0,04 Ns Ns 0,05
LATEV
(ml/m2)
26
(19-50)
21
(16-40)
20
(15-36)
19
(15-34)
<0,01 <0,01 <0,01 <0,01 <0,01
LAV p 46
(29-61)
37
(21-49
34
(20-47)
32
(18-45)
<0,01 <0,01 <0,01 <0,01 <0,01
LAPEV
(ml/m2)
13
(9-27)
11
(8-19)
10
(7-19)
10
(6-18)
<0,01 <0,01 Ns 0,03 <0,01
LAPEF
(%)
0.21
(0.15-
0.37)
0.22
(0.15-
0.35)
0.23
(0.14-
0.38)
0.24
(0.14-
0.41)
Ns Ns Ns Ns Ns
CV 30
(22-44)
33
(26-46)
34
(30-42)
36
(31-42)
<0,01 <0,01 <0,01 <0,01 <0,01
LAAEV
(ml/m2)
12
(8-23)
10
(6-21)
9
(5-17)
9
(4-16)
<0,01 <0,01 <0,01 Ns <0,01
LAAEF
(%)
0.27
(0.20-
0.51)
0.28
(0.20-
0.51)
0.28
(0.20-
0.51)
0.29
(0.16-
0.47)
Ns Ns Ns Ns Ns
Comparison of before and after PMBV LA mechanic functional parameters measured by
Transthoracic Echocardiography
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Objectıve: Rheumatic mitral stenosis (MS) is still a common disease in developing
countries with high morbidity and mortality rates. The aim of the study was to
evaluate left atrial mechanical functions in MS before and after percutaneous mitral
balloon valvuloplasty (PMBV) and following in short and mid term.
Methods: the study included 49 patients with critical mitral stenosis who have normal
sinus rhythm (male/female:14 to 35; mean age: 4211). Left atrial mechanical
functions were evaluated before, after, 3 months after and 1 year after PMBV,
including Left atrial passive emptying volume (LAPEV), LA active emptying volume
(LAAEV), LA total emptying volume (LATEV), LA passive emptying fraction
(LAPEF), LA active emptying fraction (LAAEF), LA total emptying fraction
(LATEF) and conduit volume (ﬁgure1).
Results: The transthoracic echocardiography parameters of the mitral stenosis patients
before, after, 3 months after and 1 year after percutaneous mitral balloon valvuloplasty
were as follows: a) Mitral valve area: 1.1 cm2 (0.9-1.6); 2.2 cm2 (1.8-2.8) (p<0.001);
2.2 cm2 (1.7-2.9) (NS); 2.1 cm2 (1.8-2.7) (p<0.001); b) Left atrial maximal volume:59
ml/m2 (42-76); 48 ml/m2 (34-62) (p<0.001); 44 ml/m2 (29-59) (p<0.001); 43 ml/m2
(28-57) (p<0.001); c) Left atrial passive emptying volume (LAPEV): 13 ml/m2 (9-
27); 11 ml/m2 (8-19) (p<0.001); 10 ml/m2 (7-19) (p<0.001); 10 ml/m2 (6-18)
(p<0.001);d) LA active emptying volume (LAAEV): 12 ml/m2 (8-23); 10 ml/m2 (6-
21) (p<0.001); 9 ml/m2 (5-17) (p<0.001); 9 ml/m2 (4-16) (NS) e) LA total emptying
volume (LATEV): 26 ml/m2 (19-50); 21 ml/m2 (16-40) (p<0.001); 20 ml/m2 (15-36)
(p<0.001); 19 ml/m2 (15-34) p<0.001);f) Conduit volume: 30 ml/m2 (22-44); 33 ml/
m2 (26-46) p<0.001); 34 ml/m2 (30-42) p<0.001); 36 ml/m2 (31-42) p<0.001),
respectively. However LA passive emptying fraction (LAPEF), LA active emptying
fraction (LAAEF) and LA total emptying fraction (LATEF) were not altered after
PMBV (table1).JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTConclusıon: our ﬁnding showed that improvement of left atrial mechanical functions
after successful treatment of MS with PMBV and this improvement continues for one
year.PP-215
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Background: Type 2 diabetes mellitus (DM) is a major risk factor for cardiovascular
diseases and responsible for increased cardiovascular mortality. Chronic hypergly-
cemia is related with accelerated atherosclerosis. In this study, we tried to demonstrate
the relation between glycosylated hemoglobin (HbA1c) level which is a marker of
long standing hyperglycemia and aortic stiffness which is a marker of cardiovascular
disease.
Method and Results: 100 patients with newly diagnosis type 2 diabetes mellitus were
included this study. The patients divided into 3 groups according to HbA1c level
(Group 1 HbA1c 6, group 2 HbA1c 6-7 and group 3 HbA1c >7). Statistically
signiﬁcant difference was found between groups according to blood glucose level,
DM duration and oral antidiabetic and insulin therapy (Table 1). Aortic systolic-
diastolic diameter, aortic strain and aortic distensibility were similar between group
1 and group 2 whereas in group 3, aortic systolic-diastolic diameter, aortic strain
and aortic distensibility were signiﬁcantly lower than group 1 and group 2
(p<0.001) (Table 2). Signiﬁcant correlation was found between aortic distensibility
and HbA1c level (r¼0,283; p:0,004) (Figure 1). Moreover, aortic distensibility wasERS C167
